Wolverine Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-66
Closed -$1K 1997
2015
Q3
$1K Buy
66
+8
+14% +$272 ﹤0.01% 1773
2015
Q2
$29K Hold
58
﹤0.01% 1414
2015
Q1
$42K Buy
+58
New +$2.7K ﹤0.01% 1294
2014
Q1
Sell
-43
Closed -$25K 2870
2013
Q4
$25K Buy
43
+19
+79% +$993 ﹤0.01% 2008
2013
Q3
$18K Buy
24
+11
+85% +$739 ﹤0.01% 2071
2013
Q2
$19K Buy
+13
New +$1.06K ﹤0.01% 2033

Wolverine Asset Management's ARNA Position: Q1 2022 in Review

Wolverine Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 9,880 shares — an estimated $918K sold.

Wolverine Asset Management first reported a position in ARNA in Q2 2013 and held it in 11 quarters. The position peaked at $918K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Wolverine Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 9,880 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $918K.
  • Wolverine Asset Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
  • Wolverine Asset Management's Arena Pharmaceuticals Inc position peaked at $918K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Wolverine Asset Management's 13F filing for Q1 2022, filed 4 May 2022.